Clinical experience with the use of rhG-CSF in secondary autoimmune neutropenia

Clinical and Laboratory Haematology

Volumn 24, Issue 2, 2002, Pages 93-97

  Smith, M A ^b   Smith, J G ^a,b  

^a ROYAL UNITED HOSPITALS BATH NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

G CSF; Glycosylated G CSF; Haemopoietic inhibitory T cells; Secondary autoimmune neutropenia

Indexed keywords

ALOE VERA EXTRACT; ANTIBIOTIC AGENT; AZATHIOPRINE; CIPROFLOXACIN; CYCLOSPORIN A; GRANULOCYTE ANTIBODY; IMMUNOGLOBULIN; LITHIUM CARBONATE; PENTOSTATIN; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RHESUS D ANTIBODY; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BACKACHE; BONE MARROW; CELL COUNT; CHRONOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG RESPONSE; FATIGUE; FEMALE; FEVER; HEADACHE; HEMATOPOIETIC CELL; HUMAN; INFECTION; LONG TERM CARE; MALE; MONOTHERAPY; MOUTH ULCER; MYALGIA; NAUSEA; NEUTROPENIA; NEUTROPHIL; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SIDE EFFECT; T LYMPHOCYTE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BONE MARROW EXAMINATION; COLONY-FORMING UNITS ASSAY; COMBINED MODALITY THERAPY; DRUG EVALUATION; FEMALE; FILGRASTIM; GLYCOSYLATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; NEUTROPENIA; NEUTROPHILS; OSTEOPOROSIS; SELF ADMINISTRATION; SPLENECTOMY; T-LYMPHOCYTE SUBSETS; TREATMENT OUTCOME;

EID: 0036050973     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.2002.00431.x     Document Type: Article

References (21)

1. Mutations of the granulocyte-colony stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloid leukaemia and may be a bystander phenomenon
2. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenia
3. Neutrophil antibody specificity in different types of childhood autoimmune neutropenia
4. Successful reversal of neutropenia in Felty's syndrome with recombinant granulocyte colony-stimulating factor
5. Lymphoproliferative disorder of granular lymphocytes associated with severe neutropenia. Response to granulocyte colony stimulating factor
6. Immune and idiopathic neutropenia
7. A randomised controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia
8. Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia
9. The effect of recombinant granulocyte colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia
10. Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myelogenous leukemia confer resistance to apoptosis and enhance cell survival
11. Response to granulocyte colony-stimulating-factor in an autoimmune neutropenic adult
12. Successful treatment of autoimmune neutropenia with recombinant human granulocyte-colony stimulating factor (R-met-HuG-CSF)
13. Images in haematology. Sweet's syndrome after granulocyte colony-stimulating factor administration for refractory myelodysplastic syndrome
14. The use of G-CSF (Neupogen) in patients with serologically proven autoimmune neutropenia
15. Cyclical neutropenia and T8 lymphocyte mediated stimulation of granulopoiesis
16. The occurence, subtype and significance of haemopoietic inhibitory T cells (HIT cells) in myelodysplasia: An 'in vitro' study
17. The use of granulocyte colony-stimulating factor for treatment of autoimmune neutropenia
18. Inhibition of CFU-GM by prostaglandins in a case of chronic T-cell lymphocytosis and neutropenia
19. Severe congenital neutropenia terminating in acute myeloid leukemia: Disease progression associated with mutations in the granulocyte-colony stimulating factor receptor gene
20. Detection of granulocyte alloantibodies by an indirect immunofluorescence test
21. G-CSF: A first line therapy for autoimmune neutropenia